S mooth muscle cells (SMC) of the vascular system form an intriguing population of cells that are relevant for maintaining vascular tone and function. They also play a key role in pathological processes in the vessel wall.
If we focus on the development of intimal thickening in the latter function, it is clear that even this pathological subset presents itself in various forms. That is, arteriosclerosis after hypertension, 1 atherosclerosis, 2 and restenosis after percutaneous transluminal coronary angioplasty or coronary artery bypass grafting surgery 3 have features in common as well as characteristics selective for each disease.
Relevant to an understanding of the above processes is the basic question of whether we are dealing either with a SMC heterogeneity in origin or with a spatiotemporal heterogeneity in expression of differentiation markers. To add to this complexity there is an increasing evidence that already committed and differentiated cells can transdifferentiate into another cell type. In studying SMC heterogeneity, a combination of these factors is likely.
It has been shown by several research groups that SMC heterogeneity exists within the vessel wall, varying from the adult rat 4, 5 to the human fetal population. 6 These data are mainly based on in vitro cell culture studies.
A different approach is to study the intact vascular wall and expression of differentiation markers. [7] [8] [9] [10] [11] This approach shows a change in gene expression patterns with normal maturation and with development of intimal thickening of the vessel wall. During development of intimal thickening in various settings, including physiological circumstances, 11 thickening experimentally induced by a perivascular cuff, 12 and atherosclerosis in humans, 13 reexpression of fetal genes 11 has been observed as well as altered migration and proliferation patterns as compared with normal. The most recent addition to characteristics in development of intimal thickening is the presence and, in some cases, proven increase of apoptosis. 11, 14 Whether apoptosis solely reflects cell removal or may also provide signals by, for example, local modulating factors remains to be investigated.
In this mini-review we will focus on the current knowledge about (1) SMC origin from various embryonic mesodermal progenitors and (2) phenotypic heterogeneity in neonatal and adult vessel walls in various animal models. We will combine these data and hypothesize on the origin of SMC heterogeneity.
Embryonic Smooth Muscle Origin
The vascular system in the embryo recruits its first essential building blocks, namely, endothelial cells, from the splanchnic mesoderm. It is evident that endothelial differentiation is promoted at the endodermal-mesenchymal interface, 15 although a dorsal somatic mesoderm-derived population has also recently been described. 16 As soon as the endothelial progenitors are initiated, they tend to become mobile and form a vascular network that shows great plasticity. 17, 18 The next phase in development is the acquisition of a media for the larger vessels, ie, the arteries and the veins.
There are several reasons to revisit the discussion about the splanchnic mesoderm as a sole or main contributor. First, it is generally assumed that the splanchnic mesoderm surrounding the endothelial tubes is triggered to differentiate into an SMC lineage. Cell lineage studies to support the splanchnic mesoderm contribution, however, are lacking. Second, the value of differentiation markers for characterization of adult SMC in early development has to be discussed. Until now the conclusive vascular SMC lineage marker is missing. The myo-D class for striated muscle does not have its counterpart for the SMC line.
This does not imply that we do not have valuable cytoskeletal and contractile protein markers with which to follow SMC differentiation from early development to the mature vessel wall. In the range of the contractile markers, there is an increasing list found in various animal species, including man, such as SM22, 7, 19 1E12, 20 smoothelin, 21 and smooth muscle (SM) myosin. 22, 23 It is important to note that they all are expressed in time after SM ␣-actin. 17,24 -27 All these markers have in common that in early development they are not specific for SMC, as they are expressed in skeletal and cardiac muscle as well. To study vascular maturation, SM ␣-actin turns out to be the most useful early marker that, in vivo, is not expressed in the lining endothelial cells during embryonic development. 17, 26 The value of the cytoskeletal markers desmin, vinculin, and meta-vinculin 28, 29 as SMC differentiation indicators is still being investigated. Study of a human fetal myofibroblast cell line indicates a specific role for the splice variant meta-vinculin for carrying a contractile inducing element. 28 A further reason to revisit the mesodermal origin of SMC is the evidence that has turned up from in vivo experiments in which it was shown that the first layers of SM ␣-actinexpressing cells around the endothelial cell-lined tubes transdifferentiate from the endothelium. 17 It should be studied whether this mechanism is specific for the dorsal aorta, where it was first detected (Figure 1 ), or whether it is a more general phenomenon, not only in normal development of the vessel wall, but also as a recurring process in development of intimal thickening in vessel wall disease.
Next to endothelial and splanchnic mesodermal origin, there is evidence for a number of other sources, which are in part also splanchnic mesoderm derived, such as the origin of the coronary SMC. These cells arise from the epicardial lining in a transformation process that also produces the adventitial cells of the coronary vessel wall (Figure 2a and 2b), as shown in chicken-quail chimeras by our group. 29a Similar findings have recently been reported with retroviral reporter gene tracing of epicardium. 30 In the development of the coronary vasculature, we have no evidence as yet that the endothelial cells contribute to the SMC population by transdifferentiation.
A final proven SMC source, previously attributed to endothelial cell-SMC transformation, is that of neurectodermal origin, 31 namely, the mesectoderm of the neural crest. Careful mapping in chicken-quail chimeras 32, 33 and with retroviral reporter gene transfer experiments 33, 34 shows that neural crest cells can differentiate into SMC in the thorax, head, and neck arteries. In part this has been described earlier. 31, 35 What is new is that neural crest cells are also present in the wall of the cardinal veins. 33 Neural crest mapping shows that there are marked boundaries ( Figure 3 ) between the vessels that do and do not contain . Note the sharp boundary in this heart-lung specimen between neural crest and non-neural crest cells (arrow) at the arterial pole of the heart. This heart-lung specimen is from a chick embryo that was sacrificed at stage 39. A indicates atrium; and V, ventricle.
neural crest cells. 33, 36 Non-neural crest arteries are the pulmonary arteries, the coronary arteries, and the subclavian arteries. A summary of known sources is presented in the Table. In studying the origin of the vascular SMC there is clear evidence that the SMC and the fibroblast have many features in common regarding their origin. This is supported by our own studies on neural crest homing 33 and on the origin of SMC and fibroblasts of the coronary vasculature (Figure 2a and 2b), as well as from data on endothelial SMC transformation (Figure 1) , in which the adventitia of these vessels has a similar embryonic contribution as the media, suggesting a common origin of fibroblasts and SMC.
Summarizing the data on SMC origin, we can state that SMC were experimentally proven to originate from the neurectoderm (neural crest) and from multiple mesodermal sources that have undergone differentiation to some extent (endothelium, epicardium). In addition, alleged media acquisition from the still undifferentiated splanchnic mesoderm undoubtedly plays a pivotal role, but was not yet verified by lineage studies.
SMC Heterogeneity In Vivo and In Vitro
Heterogeneity of SMC is a well-known phenomenon. The interpretation, however, of the morphologic phenotype as well as the functional implications of the expression of differentiation markers is subject to much debate. The data are derived from in vivo or in vitro studies. The material used varies from adult to neonatal to fetal vessels and cells from different animal species. The origin of the cultured cells can be from intima, inner or outer media, or the adventitia in both normal and diseased vessels.
The data from in vitro studies are largely reflected in in vivo studies. Proceeding from data in early fetal development, it has been shown that the SMC start to express SM ␣-actin 17 followed by 1E12, 20 an actinin marker, and smoothelin. 21 Relative late differentiation markers are the already mentioned markers, such as SM22, calponin, h-caldesmon, 7 and SM myosin. 8 These are upregulated until the expression level of the mature vessel wall is reached. 9, 11 During this developmental period, there are also a number of markers that are downregulated, such as cytokeratin 37 and certain fibronectin splice variants. 11, 29, 38 When the various vessel wall layers are taken into account, the SMC at the intimal side of the vessel wall are less differentiated as compared with the middle and outer media. 11, 39 On development of intimal thickening, either as a physiological process as in the ductus arteriosus 11, 40, 41 or as arteriosclerotic processes 42 and restenosis, 3 the reexpression of fetal genes is generally reported.
In general, the SMC are oriented circumferentially in the outer media, but close to the lumen they appear in a more random fashion. A few vessels show clusters of cells with a specific differentiation pattern. In the bovine pulmonary arteries, clusters of cells express meta-vinculin in a stable fashion during maturation, 8 allowing for the differentiation of a subpopulation of contractile cells. A possibly different phenomenon is seen in the ductus arteriosus, in which during the closing process and the concomitant reexpression of fetal genes, clusters of cytokeratin-positive cells appear after general fetal cytokeratin expression was already lost. 37 Combining the data from the in vitro studies, it can be concluded that from a morphologic point of view we can differentiate between at least 2 SMC phenotypes, namely the epithelioid and the spindle-shaped 4,43 cell. To these can be added the thin elongated cell and the senescent type. 4 These morphologically identified types most probably coincide with the more functional in vivo classification of contractile (resembling the spindle-shaped) and synthetic (resembling the epithelioid-shaped) cell types. 44 The synthetic cell type is in some studies referred to as a nonmuscle phenotype because it lacks the contractile differentiation markers. 27 The distinction of the SMC into a pup and a type 45, 46 brings the pup within the epithelioid range and the mu within the spindleshaped range. Comparing fetal, neonatal, and adult data, phenotypic differences are already evident from early development onward but tend to become more prominent. The phenotypes are particularly obvious in the adult vessel wall, with a preference but not a selective presence of the synthetic type in the intima and the contractile cell in the media. Culture studies show that these phenotypic characteristics are relatively stable, at least when a confluent monolayer is achieved. 44 The spindle-shaped phenotype has been described as being able to alter its phenotype to an epithelioid phenotype when culture conditions are suboptimal. 44 Whether this change in phenotype can also be observed in vivo remains to be proven. The studies of Bochaton-Piallat et al 4 show that both the intimal layer and the media contain a mixture of the various phenotypes. The ultimate fate of the SMC phenotypes is not identical, because the epithelioid/synthetic type is more prone to apoptosis both in vitro and in vivo 14 in physiological 11 and in pathological intimal thickening. 3, 47 The morphologic phenotype does correlate in general with the expression of certain differentiation markers. The spindleshaped cells, accounting for the majority of the so-called contractile SMC, express differentiation markers such as SM22, calponin, and h-caldesmon, 7 which relate to the contraction capacity of the cells. The expression of these markers is preceded by some fibronectin differentiation markers, such as fibronectin splice variants, troponin, and vinculin. These markers are more obvious in the fetal SMC phenotype, and some are lost in the neonatal and adult cell culture studies. A reexpression of these markers is seen in development of intimal thickening, 42 
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in cytolytic necrosis of the media, as seen in the ductus arteriosus during the closing process. 11 The reexpression of fetal markers is accompanied by an increase in apoptosis. 3, 11 The fetal cytoskeletal differentiation markers seem to persist in the so-called myofibroblast cell lineage. 28 The role of this intriguing cell type either as an adventitial cell or as a smooth muscle stem cell remains to be investigated. In whole vessel wall organ cultures it has been shown that these myofibroblasts migrate from the adventitia to the luminal surface, where they transdifferentiate into an endothelial-like cell lining the lumen, as well as into a synthetic phenotype SMC in the intimal thickening. 48 In this respect the so-called dendritic cells 49, 50 also need further investigation as their origin and role are still obscure.
The possible presence of a quiescent population of SMC that serves as a progenitor for the synthetic cell type will be discussed in the paragraph on relation of origin and phenotype.
In general, SMC heterogeneity is eminent both in in vitro and in vivo studies. For the latter experiments, the range of phenotypic expression is broader, as expected. This might bear relevance for the understanding of pathologic conditions.
Elastic Versus Muscular Differentiation
A major point that has not been solved until now concerns regulation of differentiation of vessels into an elastic or a muscular phenotype. 27 The blood vessel architecture is well adjusted to the demands of maintaining blood pressure and propelling blood to the various organs, but the how and why of differentiation of a particular vessel into, for example, an elastic ascending aorta, a muscular coronary artery, and a muscular ductus arteriosus with intimal thickening remains elusive. In this matter, early regulatory genes, such as hox genes that determine pharyngeal arch patterning 51 or the paired-related homeobox genes Prx1 and Prx2 52,53 that have a vessel wall expression, do not easily explain vessel wall patterning. The ductus arteriosus remains an intriguing vessel as it shows a peculiar pattern for many molecules (Figure 4 ). There is a very high expression of angiotensin II (Blankesteÿn WM, Gittenberger-de Groot et al, unpublished data, research started in 1996 and still in progress) in the fetal ductus as well as a high ductus-restricted expression of Prx2. 52, 53 The outer media of the ductus shows retinoic acid-responsive signaling, 54 which also gives no further clue as to its meaning except that it correlates with a more differentiated SMC population. 11, 39 In conclusion, the regulation of the vessel wall differentiation pattern and its boundaries are not well understood. It is too simple to hold hemodynamic parameters solely responsible. Most probably, regulating genes, cell origin, and functional demands interact in the resulting vessel wall phenotype.
Correlation of Origin and Heterogeneity of SMC
The specific characteristics of the SMC in intimal thickening in atherosclerosis have put several investigators on an interesting conceptual course of allowing these cells to be monoclonal in origin, deriving possibly from a single source. 55 The origin of such a stem cell could in principle reside in both mesoderm and mesectoderm, ie, the sources of SMC. As intimal thickening as a pathologic process takes place in many vessels that may or may not contain a neural crest SMC-derived component (Table) , neural crest cells do not seem to supply a specific SMC phenotype or more specifically an SM stem cell. There are indications, however, that neural crest-derived SMC do have a modulating effect on the formation of the elastic wall structure, 27, 56 but this is a relatively late phenomenon. Neural crest-derived SMC behave differently from mesoderm-derived cells, which can be deduced from in vitro culture studies that show a different reaction pattern of SMC to transforming growth factor-␤. 57, 58 The problem in the analysis of this in vitro study is that it does not reflect the muscular and nonmuscular SMC phenotypes that have been shown by Bergwerff et al 33 (Figure 5a and 5b) to both have a neural crest background. A second stem cell candidate may be the endothelial cell 17 that was recently described to transdifferentiate into an SMC. Tracing of these cells, by means of a retrovirally introduced reporter gene, shows that the endothelial cells end up in the media (Figure 1 ) and even migrate into the adventitia. Here they coexpress the reporter gene and the SMC markers caldesmon and calponin (not shown). It remains to be investigated whether in normal development all atherosclerosis-prone vessels have acquired an endothelial cell-derived SMC contribution. In this respect also the adventitial fibroblast may play a role, although this cell also has a variable embryonic background.
In conclusion, we can state that SMC have a variable embryonic origin throughout the body. In relation to this origin, a variation in differentiation can be seen but not to the level of altering the basic elastic and muscular arterial patterning. 
Conclusions
During development and with increasing maturation, SMC acquire 2 to 4 morphologic phenotypes 4, 8, 44 that have their preferential sites within the vessel wall layers. In experimental in vitro conditions these cells can be forced to change their phenotype but it is also possible with careful selection of the in vitro culture conditions to maintain a stable phenotype for many passages. In the in vivo situation these phenotypes can be traced to preferential sites within the vessel wall. There is evidence that the SMC phenotypes retain their differentiation state under normal circumstances. In disease it remains to be proven whether there is really a phenotypic modulation of one cell type into another, or whether the stem cell populations provide for the required phenotype. In vivo vessel wall studies with reporter gene tracing in the chicken model will be relevant to solve this problem. If transgenic mice can be devised that retain the endothelial cell and SMC promotor activity (eg, based on the Cre-loxP recombination system), phenotypic differentiation changes can be monitored. There is as yet no convincing evidence that the SMC heterogeneity has an origin-based background. 
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